Aipuqiang key facts
as of Oct 2026- Manufacturer of proton therapy systems designed for hospitals, cancer treatment centers, and healthcare institutions.
- Aipuqiang is valued at approximately $135.2M as of Oct 2026 (last reported valuation).
- It has raised $254.3M; the latest was Later Stage VC ($141.7M) in Dec 2025.
- Notable investors include New Alliance Capital, Xuhui Hi-Tech, Shanghai Alliance Investment, Shanghai Information Investment, Jiading Industry Development Group — 11 tracked in total.
- Status: Privately Held (backing).
Aipuqiang's last reported valuation, Jun 2023. Nothing priced has surfaced since.
- ·The complete investor list: 11 names
- ·Watch Aipuqiang: the Monday email on marks, rounds and moves
Aipuqiang funding rounds
No funding rounds for Aipuqiang are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Aipuqiang
11+Aipuqiang valuation
Aipuqiang's last reported valuation was $135 million in Jun 2023. No priced round, secondary trade or fund mark has surfaced since.
Aipuqiang investors
11 investors are on record for Aipuqiang, including New Alliance Capital, Xuhui Hi-Tech, Shanghai Alliance Investment and Shanghai Information Investment.
About Aipuqiang
Manufacturer of proton therapy systems designed for hospitals, cancer treatment centers, and healthcare institutions. The company focuses on the research and development of proton therapy devices, thereby enabling clients to provide patients with state-of-the-art, non-invasive cancer therapy options that improve treatment outcomes.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2011
- Employees
- 68
- Website
- aptr.com.cn/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.